Healthcare Regulation (HIPAA)

A silent barrier in diabetes care, 'clinical inertia,' leaves patients at risk. New research shows how empowering pharmacists with targeted education can turn the tide.

EXL's new Gold Tier status with Databricks isn't just a partnership upgrade; it's a strategic move to solve AI's biggest business problem: data governance.

A new partnership between isolved and PosterElite aims to automate labor law compliance, a complex and costly administrative headache for employers in the modern era.

Echo IQ partners with Mayo Clinic to test its AI for cardiac risk in cancer patients, a key move for validation in the burgeoning cardio-oncology sector.

Jazz Pharma's lung cancer drug Zepzelca fails a key trial, raising regulatory questions. Yet its strength in another setting reveals a complex drug development system.

MBX Biosciences' new one-year data for canvuparatide isn't just a clinical win; it's a calculated move to dominate a billion-dollar market left vacant.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

As youth nicotine pouch use soars, Imperial Tobacco Canada calls for a crackdown on illicit sales. But is this a genuine public health plea or a masterful play to secure its market?

As Ontario doctors adopt AI to fight burnout, a new training program from OntarioMD tackles the urgent medico-legal and privacy risks head-on.

With its $30M purchase of CareSeed, Sagility is betting on AI-driven analytics to move beyond compliance and redefine healthcare quality and financial outcomes.

With over 55,000 on waitlists for the UK's first oral weight-loss pill, the market is set to explode. But strict rules and high hopes face a reality check.

As AI transforms healthcare, ECLAT Health Solutions secures the coveted HITRUST r2 certification, setting a new benchmark for data protection and trust.

For 17 years, Jeffrey Phillips helped California revoke professional licenses. Now, he's joined the defense. His move reveals a crucial shift in the high-stakes world of regulatory law.

For millions, the 'why' behind infertility remains a mystery. New genomic mapping tech is finally providing answers, changing the landscape of family planning.

Sweeping data from EHA 2026 shows Syndax's Revuforj achieving remarkable success across leukemia settings, signaling a new standard of care and a major market coup.

A key deal locking in generic drug prices is extended, promising billions in savings for healthcare and providing crucial stability for a fragile industry.

Amid a national teacher crisis, Dr. Veronica Bradley's "Why Stay?" shifts the focus from attrition to retention, commercializing a new theory of resilience.

Dissecting the Med-Metrix acquisition of CanAide. A strategic move by private equity to capture the booming RCM market by tackling provider costs and patient access.

A new Florida venture embeds sleep apnea treatment into cardiology care, a model that could reshape patient outcomes and Vivos Therapeutics' market strategy.

A market set to triple, driven by gene-level therapies, promises a revolution for children with rare epilepsies. But can our systems deliver this hope?